304 related articles for article (PubMed ID: 22801304)
1. [Transcatheter interventional therapy of congenital heart disease: the results of Chinese TIT registry].
Li JJ; Zhang ZW; Qian MY; Li YF; Wang SS;
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Apr; 40(4):283-8. PubMed ID: 22801304
[TBL] [Abstract][Full Text] [Related]
2. [Analysis and follow-up study on 8 children with combined congenital heart disease treated with simultaneous trans-catheter therapy].
Cheng SQ; Liu JP; Sun X; Li J; Zhang J; Liu LW; Deng YL; Niu YC
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):599-602. PubMed ID: 18947479
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous transcatheter treatment of perimembranous ventricular septal defect and other congenital cardiopathies.
Xu XD; Bai Y; Chen XL; Liu SX; Zhao XX; Qin YW
Heart Lung Circ; 2014 Dec; 23(12):1169-74. PubMed ID: 24998101
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter closure of congenital ventricular septal defects: results of the European Registry.
Carminati M; Butera G; Chessa M; De Giovanni J; Fisher G; Gewillig M; Peuster M; Piechaud JF; Santoro G; Sievert H; Spadoni I; Walsh K;
Eur Heart J; 2007 Oct; 28(19):2361-8. PubMed ID: 17684082
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
[TBL] [Abstract][Full Text] [Related]
6. [Transcatheter therapy of combined congenital heart diseases in children].
Zhang YY; Zhu WH; Xia CS; Gong FQ; Xie CH; Huang XM; Kang ML
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 May; 35(3):327-30. PubMed ID: 16764039
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of Down syndrome with congenital heart disease: a 5-years registry at QSNICH.
Layangool T; Sangtawesin C; Kirawittaya T; Prompan W; Prachasilchai P; Pechdamrongsakul A
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S108-14. PubMed ID: 25391181
[TBL] [Abstract][Full Text] [Related]
8. [Effects of intraoperative hybrid procedures for the treatment of congenital heart disease].
Hu SS; Li SJ; Zhang H; Sun HS; Shen XD; Wang H; Jiang SL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):236-9. PubMed ID: 16630458
[TBL] [Abstract][Full Text] [Related]
9. [Complications of transcatheter interventional occlusion of ventricular septal defects].
Zhang YS; Li H; Liu JP; Dai ZX; Wang L; Zhang J; Li J; Wang XY
Zhonghua Er Ke Za Zhi; 2005 Jan; 43(1):35-8. PubMed ID: 15796806
[TBL] [Abstract][Full Text] [Related]
10. Variation in practice patterns in device closure of atrial septal defects and patent ductus arteriosus: An analysis of data from the IMproving Pediatric and Adult Congenital Treatment (IMPACT) registry.
O'Byrne ML; Kennedy KF; Rome JJ; Glatz AC
Am Heart J; 2018 Feb; 196():119-130. PubMed ID: 29421004
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of congenital muscular ventricular septal defect.
Arora R; Trehan V; Thakur AK; Mehta V; Sengupta PP; Nigam M
J Interv Cardiol; 2004 Apr; 17(2):109-15. PubMed ID: 15104774
[TBL] [Abstract][Full Text] [Related]
12. Clinical analysis of transcatheter closure of perimembranous ventricular septal defects with occluders made in China.
Li X; Li L; Wang X; Zhao HB; Zhang SY
Chin Med J (Engl); 2011 Jul; 124(14):2117-22. PubMed ID: 21933612
[TBL] [Abstract][Full Text] [Related]
13. [Interventional therapy for structural heart diseases in People's Liberation Army hospitals between 2005 and 2006].
Zhu XY; Zhang DZ;
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jul; 36(7):608-12. PubMed ID: 19100088
[TBL] [Abstract][Full Text] [Related]
14. [Clinical follow-up of staged hybrid approach for patients with ventricular septal defects combined with patent ductus arteriosus and pulmonary hypertension].
Yang J; Yang LF; Liu JC; Yu SQ; Zuo J; Jin ZX; Chen T; Yi DH; Zhang J; Li J
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):128-31. PubMed ID: 21426746
[TBL] [Abstract][Full Text] [Related]
15. Impact of transcatheter occlusion of a patent ductus arteriosus on atrial septal defect diameter in children.
Stapleton GE; Eidem BW; Pignatelli RH; Carlson KM; Mullins CE; Grifka RG
Congenit Heart Dis; 2006 May; 1(3):116-9. PubMed ID: 18377555
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias.
Wilson NJ; Smith J; Prommete B; O'Donnell C; Gentles TL; Ruygrok PN
Heart Lung Circ; 2008 Aug; 17(4):318-24. PubMed ID: 18407789
[TBL] [Abstract][Full Text] [Related]
17. Procedural results and safety of common interventional procedures in congenital heart disease: initial report from the National Cardiovascular Data Registry.
Moore JW; Vincent RN; Beekman RH; Benson L; Bergersen L; Holzer R; Jayaram N; Jenkins K; Li Y; Ringel R; Rome J; Martin GR;
J Am Coll Cardiol; 2014 Dec; 64(23):2439-51. PubMed ID: 25500227
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience.
Szkutnik M; Kusa J; Białkowski J
Kardiol Pol; 2008 Sep; 66(9):941-7; discussion 948-9. PubMed ID: 18924021
[TBL] [Abstract][Full Text] [Related]
19. [Recent strategies for a cyanotic heart disease].
Miyaji K
Kyobu Geka; 2011 Jul; 64(8 Suppl):679-84. PubMed ID: 21916178
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of postoperative residual ventricular septal defects using Amplatzer-type perimembranous VSD occluders.
Zhang B; Liang J; Zheng X; Jiang G; Yang Z; Zhang L; Zhang Y; Sun H
J Invasive Cardiol; 2013 Aug; 25(8):402-5. PubMed ID: 23913605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
